Sandoz Group AG
SIX:SDZ
Sandoz Group AG
Operating Income
Sandoz Group AG
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Sandoz Group AG
SIX:SDZ
|
Operating Income
$1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Novartis AG
SIX:NOVN
|
Operating Income
$16.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
4%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Operating Income
-$15.5m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Roche Holding AG
SIX:ROG
|
Operating Income
CHf18.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Sandoz Group AG's Operating Income?
Operating Income
1.4B
USD
Based on the financial report for Dec 31, 2022, Sandoz Group AG's Operating Income amounts to 1.4B USD.
What is Sandoz Group AG's Operating Income growth rate?
Operating Income CAGR 1Y
-19%
Over the last year, the Operating Income growth was -19%.